Search Results - "van Lieshout, Laura A M"

Patients’ and professionals’ perspectives on implementation of opportunistic salpingectomy: a mixed-method study by Gelderblom, Malou E, Van Lieshout, Laura A. M, Piek, Jurgen M. J, De Hullu, Joanne A, Hermens, Rosella P. M. G

“…Abstract Background To prevent ovarian cancer, several international societies have issued guidelines which recommend to discuss opportunistic salpingectomy…”
Get full text

Functional estrogen receptor signaling pathway activity in high-grade serous ovarian carcinoma as compared to estrogen receptor protein expression by immunohistochemistry by van der Ploeg, Phyllis, van Lieshout, Laura A. M., van de Stolpe, Anja, Bosch, Steven L., Lentjes-Beer, Marjolein H. F. M., Bekkers, Ruud L. M., Piek, Jurgen M. J.

“…Purpose Anti-estrogen therapy may be used as a palliative treatment option in high-grade serous ovarian carcinomas (HGSC). However, clinical implementation is…”
Get full text

Hysterectomy with opportunistic salpingectomy versus hysterectomy alone by van Lieshout, Laura A M, Steenbeek, Miranda P, De Hullu, Joanne A, Vos, M Caroline, Houterman, Saskia, Wilkinson, Jack, Piek, Jurgen Mj

“…Ovarian cancer has the highest mortality rate of all gynaecological malignancies with an overall five-year survival rate of 30% to 40%. In the past two decades…”
Get more information

Primary prevention of ovarian cancer: a patient decision aid for opportunistic salpingectomy by van Lieshout, Laura A.M., Gelderblom, Malou E., de Hullu, Joanne A., The, Regina, van Ginkel, Alexandra A., Oerlemans, Anke J.M., Smeets, Kirsten M.W.H., Schreurs, Malou P.H., Piek, Jurgen M.J., Hermens, Rosella P.M.G.

“…The discovery of the fallopian tube epithelium as the origin of high-grade serous ovarian cancer has brought a new option for ovarian cancer prevention. The…”
Get full text

The rapid adoption of opportunistic salpingectomy at the time of hysterectomy for benign gynecological disease in the United States by Piek, Jurgen M J, van Lieshout, Laura A M, Hermens, Rosella P M G, Gelderblom, Malou E, van Lieshout, Laura A M, de Hullu, Joanne A

Get full text

Factors influencing decision-making around opportunistic salpingectomy: a nationwide survey by Steenbeek, Miranda P, van Lieshout, Laura A M, Aarts, Johanna W M, Piek, Jurgen M J, Coppus, Sjors F P J, Massuger, Leon F A G, Hermens, Rosella P M G, de Hullu, Joanne A

“…To explore current practice and influencing factors on adoption of the opportunistic salpingectomy (OS), particularly regarding the decision making, to…”
Get full text

The rapid adoption of opportunistic salpingectomy at the time of hysterectomy for benign gynecological disease in the United States by Piek, Jurgen M.J., van Lieshout, Laura A.M., Hermens, Rosella P.M.G., Gelderblom, Malou E., de Hullu, Joanne A.

“…Mounting evidence for the role of the distal fallopian tubes in the pathogenesis of epithelial ovarian cancer has led to the increased performance of…”
Get full text

Primary Prevention of Ovarian Cancer: A Patient Decision Aid for Opportunistic Salpingectomy by Van Lieshout, Laura A. M., Gelderblom, Malou E., De Hullu, Joanne A., The, Regina, Van Ginkel, Alexandra A., Oerlemans, Anke J. M., Smeets, Kirsten M. W. H., Schreurs, Malou P. H., Piek, Jurgen M. J., Hermens, Rosella P. M. G.

“…(Abstracted from Am J Obstet Gynecol 2021; doi10.1016/j.ajog.2021.09.010) The site of origin of the most common ovarian cancer subtype—high-grade serous—is the…”
Get full text